Proxy Materials

Perspective Therapeutics, Inc. Filed 2024-04-18 Acc 0000950170-24-045557

Documents 1

2025-04-16 DEFA14A Proxy Materials
2024-04-24 4 VP Finance/Prin Fin&Acct Offic acquired 30,000 shares (option exercise)
2024-04-19 SC 13G Amended Statement of Ownership
2024-04-18 DEFA14A Proxy Materials
2024-04-18 DEF 14A Proxy Statement
2024-04-16 8-K Acquisition or sale completed
2023-08-22 DEFA14A Proxy Materials

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading def_-_notice_internet_av.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…